8.07 USD
↘ 0.37 (4.38%)AT CLOSE (11:59 AM EDT)
Emergent Biosolutions, Inc.
EBSNYSE • USD
8.21
↗ 0.14 (1.74%)
POST MARKET (AS OF 08:12 PM EDT)
Post Market
AS OF 08:12 PM EDT
8.21
↗ 0.14 (1.74%)
Market: CLOSED
Open?$8.38
High?$8.51
Low?$7.95
Prev. Close?$8.44
Volume?701.5K
Avg. Volume?787.8K
VWAP?$8.13
Rel. Volume?0.89x
Bid / Ask
Bid?$7.75 × 100
Ask?$8.72 × 100
Spread?$0.97
Midpoint?$8.24
Valuation & Ratios
Market Cap?416.4M
Shares Out?51.6M
Float?50.6M
Float %?98.0%
P/E Ratio?N/A
P/B Ratio?0.80
EPS?-$0.17
Dividend?0.00%
Ex-Dividend?N/A
Emergent Biosolutions, Inc. (EBS) trades at $8.07 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest EBS is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Jun 5, 2026.
RelatedJNJ
News
Profile
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
Themes
Employees
900
Market Cap
416.4M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2006-11-15
Address
300 PROFESSIONAL DR
GAITHERSBURG, MD 20879
Phone: 240-631-3200
GAITHERSBURG, MD 20879
Phone: 240-631-3200
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?15
Momentum?50
Short Sent.?19
Piotroski F-Score?3/9Weak
Altman Z-Score?1.26Distress
Confidence?68%Moderate
Short InterestVery High
Short % of Float?18.98%High
Short Interest?9.6M
Days to Cover?12.0
Free Float50.6M
Avg Daily Volume800.7K
Settlement Date2026-05-15
Financial Health
Current Ratio?4.28Strong
Quick Ratio?2.08Strong
Cash Ratio?1.08Strong
Debt/Equity?1.10Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.80CHEAP▾
Peers100
S&P97
P/S?0.62CHEAP▾
Peers100
S&P93
P/FCF?3.1CHEAP▾
Peers100
S&P97
EV/EBITDA?5.0CHEAP▾
Peers100
S&P97
EV/Sales?1.23CHEAP▾
Peers100
S&P88
Returns & Efficiency
ROE?-1.6%WEAK▾
Peers50
S&P14
ROA?-0.7%WEAK▾
Peers50
S&P6
Cash Flow & Enterprise
FCF?$135.4M
Enterprise Value?$829.7M
Fundamentals ratios updated end of day